483
Novocol Pharmaceutical of Canada, Inc.Novocol Pharmaceutical of Canada, Inc. – FDA 483, Jun 18, 2019
Record Details
Novocol Pharmaceutical of Canada, Inc. was cited for three observations during an FDA inspection. The firm failed to follow established procedures for preventing microbiological contamination of sterile drug products, including visual inspection qualification and semi-automated inspection protocols. Additionally, the company did not properly document and evaluate recurring priority 1 alarms as required by its alarm response procedure.
View Company Profile
ID · 7485559c-7f8a-451d-a20e-1683858db483
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.